Zdrowie i gospodarka · 03/08/1999

FDA Releases Draft Guidance on Cooperative Manufacturing Arrangements for Licensed Biologics

The FDA is releasing a draft guidance on cooperative manufacturing arrangements for licensed biologics, aiming to increase flexibility in manufacturing and licensing while maintaining public health protection. The revised guidance reflects recent changes in biologics regulations.